Delivery Order SPE2DB22D2206-SPE2DB25FEY47

Award Date 1/3/25
Potential Completion Date 1/27/25
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distributor, a delivery order contract worth $49,752.80 for the supply of GAMUNEX-C 40 gram/400 ml vials. The contract has a firm fixed price and an ultimate completion date of January 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of GAMUNEX-C 5 gram/50 ml vial. The order has a firm fixed price of $2,959.30 and a period of performance through September 30, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to deliver a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,325.64 firm fixed-price delivery order is for the supply of GAMUNEX-C 10 gram/100 ml vials and has an ultimate completion date of January 27, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of the drug GAMUNEX-C 20 gram/200 ml vial. The $7,394.46 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of December 18, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,950.56 firm fixed price delivery order covers the supply of GAMUNEX-C 40 gram/400 ml vials, with an ultimate completion date of December 19, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
The U.S. Department of Defense (DOD) Defense Logistics Agency (DLA) Troop Support Medical has awarded a delivery order contract valued at $28,854.48 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution services company. The delivery order is for the product GAMUNEX-C 40 GRAM/400 ML VIAL 400ML and has a period of performance through April 1, 2024. This award is part of a larger $999,999,999.00 indefinite delivery contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,125.92 firm-fixed-price delivery order is for the supply of 4566734911 - GAMUNEX-C 20 GRAM/200 ML VIAL 200ML. The contract has an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order worth $57,708.96 issued by the Defense Logistics Agency (DLA), a defense agency. The contract provides for the delivery of GAMUNEX-C 40 gram/400 ml vial, a pharmaceutical product, with a period of performance through May 29, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distribution company that...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $59,703.36, is for the delivery of GAMUNEX-C 40 gram/400 ml vials. The contract is a Firm Fixed Price Delivery Order and has an ultimate completion date of December 12, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,731.46 firm fixed-price delivery order is for the medical product "GAMUNEX-C 10 GRAM/100 ML VIAL 100ML" and has an ultimate completion date of January 8, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FEY47
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $27,926.40, is for the supply of GAMUNEX-C 40 gram/400 ml vials. The contract is a firm fixed-price delivery order without any set-aside designation, indicating open competition.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 4/4/25, 10:05 AM